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Abstract
Background: Effective and efficient care is required to prevent the spread of infectious pulmonary
tuberculosis (PTB). We attempted to compare care quality among different healthcare institutions
in Southern Taiwan.
Methods: This study conducted population-based retrospective cohort design. One tuberculosis
sanatorium, 2 medical centers, 11 regional hospitals, and 15 district hospitals and primary
practitioners in the study area had reported tuberculosis cases, registered from January 1 to June
30 2003. Those cases with sputum positive PTB were followed 15 months after anti-tuberculosis
treatment initiation. Meanwhile, Level of conformance with diagnostic guidelines, efficiency of
diagnostic and treatment process, and treatment were measured as main outcome. Association
was investigated using Chi-square tests, Kruskal Wallis tests, Mann-Whiteney U tests, and multiple
logistic regression analysis to evaluate outcome differences among different levels of institutions.
Results: The analyses included 421 patients. In comparison with patients receiving treatment at
medical centers, regional hospitals, and district hospitals/primary practitioners, patients at the
Chest Specialty Hospital were more likely to provide at least three sputum specimens (74.1% vs.
48.2%, 36.8%, and 50.0%), shorter workdays examining sputum smears (2.4 ± 2.4 days vs. 2.6 ± 2.1,
4.5 ± 3.1, and 3.5 ± 2.6 days), shorter interval between the first consultation and treatment (10.1
± 18.3 days vs. 31.0 ± 53.6, 31.2 ± 70.4, and 25.4 ± 37.6 days), and a higher successful treatment
rate (92.6% vs. 65.2%, 63.9%, and 68.0%). Furthermore, after adjusting age and gender, the patients
treated by the pulmonologists and treated at Chest Specialty Hospital had significantly more
successful treatment rate, of which odds ratios were 1.74 and 4.58 respectively.
Conclusion: Differences in care quality exist among different types of healthcare institutions and
among individual physicians. The implementation of practice guidelines should contribute to an
improvement in the care quality of the treatment and diagnosis of PTB.
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Background
Pulmonary tuberculosis is a global problem currently
resulting in the death of approximately 2 million people
each year. If more stringent control is not implemented,
approximately 1 billion people will become newly
infected, 150 million people will become symptomatic,
and 36 million will die from the disease between 2002
and 2020 [1].
For the past several decades, Taiwan committed itself to
reduce the epidemic of tuberculosis. The mortality rate
from tuberculosis has decreased from more than 100
cases per 100,000 people in the early 1950s to 5.8 cases
per 100,000 people in 2003. However, in recent years,
newly infected tuberculosis cases appear to be on the
increase; the incidence rate has increased from approxi-
mately 50 cases per 100,000 in the early 1990s to more
than 60 per 100,000 since the late 1990s [2]. Tuberculosis
remains the leading infectious cause of death in Taiwan.
The control of tuberculosis remains one of the major chal-
lenges faced by Taiwan's health care administration.
Taiwan's health care system has been significantly
reformed in recent years. Two reform policies, which have
profoundly influenced tuberculosis care are: (1) the intro-
duction of the National Health Insurance and (2) the
restructure of the tuberculosis control system. In 1995,
Taiwan implemented a compulsory universal health
insurance program for its residents. This program main-
tains a contract with more than 90% of Taiwan's health
care institutions and without a referral system, insured
persons are provided with complete freedom regarding
choice of physician [3]. Thus, all patients with tuberculo-
sis can freely seek medical aid at any healthcare institution
from offices of primary practitioners to hospitals.
Previously, Taiwan adopted a dedicated tuberculosis con-
trol system with an extensive network reaching each town-
ship. This system effectively contained the spread of
tuberculosis. However, during the late 1990s, the govern-
ment-owned health care institutions underwent a dra-
matic reorganization. The tuberculosis control system was
merged into the general health care system. Four sanatoria
institutions located in northern, central, and southern Tai-
wan were reduced to one. In 2001, the Chest Specialty
Hospital was the only remaining tuberculosis sanatorium.
These two influencing policies have resulted in an increas-
ing trend in the number of tuberculosis patients treated by
institutions other than tuberculosis sanatoria. By 2001,
only 10% of all patients with tuberculosis were reported
by tuberculosis sanatoria [4]. However, at the same time,
the number of newly reported patients had increased,
with a reporting rate of 75 cases per 100,000 people in
2002. Moreover, the cure rate for newly diagnosed pulmo-
nary tuberculosis patients was 75%, which is lower than
the 85% target set by the World Health Organization
(WHO) [5].
To effectively contain the spread of tuberculosis, the avail-
ability of quality medical care to patients is essential. The
efficiency of the diagnosis process and effective treatment
for cases with infectious pulmonary tuberculosis (PTB)
are important factors. Therefore, the purpose of this study
was to evaluate the quality of diagnosis and treatment at
different levels of healthcare institutions in Taiwan.
Methods
A population-based medical record review in southern
Taiwan, where the study perimeters included four admin-
istrative areas: Chiayi County, Chiayi City, Tainan
County, and Tainan City, covering 2.7 million residents,
was performed. As authorized by law in Taiwan, all sus-
pected and confirmed tuberculosis cases should be
reported in a timely manner to the national computerized
registry, maintained by the Center for Disease Control
(CDC). Reporting of cases has been encouraged and rein-
forced through the implementation of a no-notification-
no-reimbursement policy and the notification-for-fee pol-
icy since 1997 [6]. We requested data on all suspects and
confirmed tuberculosis patients residing in the studied
areas from the registry for the period January 1 to June 30,
2003.
Site visits to hospitals were arranged to review the medical
records of each patient. Prior to these visits, the team,
including four registered nurses (each with a minimum of
6 years clinical experience), two chief nurses (each with a
minimum of 12 years clinical experience), and one pul-
monologist, had received a series of training courses. The
training was designed to ensure proper validation of data
consistency. Medical records of the diagnostic and treat-
ment processes were reviewed.
Infectious PTB
Infectious PTB is referring to sputum culture-confirmed
disease caused by Mycobacterium tuberculosis or two spu-
tum smear examinations positive for acid-fast bacilli [7].
Healthcare institutions
The institutions that had reported cases in the study area
included the Chest Specialty Hospital (the only remaining
tuberculosis sanatorium in Taiwan, which is geared
towards specialized thoracic disease care, mainly for
tuberculosis), 2 medical centers, 11 regional hospitals,
and 15 district hospitals and primary practitioners (dis-
trict hospitals and primary practitioners are regarded as at
the same level in terms of the treatment of tuberculosis).
In addition to inpatient services, hospitals in Taiwan pro-
vide considerable outpatient services, accounting for
approximately 50% of their revenues, and are accreditedBMC Public Health 2007, 7:107 http://www.biomedcentral.com/1471-2458/7/107
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by three levels. Medical centers, housing over 500 acute
staffed beds, are designated to assume the responsibilities
of providing healthcare services, training medical profes-
sionals, and conducting research. Regional hospitals have
no less than 250 acute beds and are staffed with physi-
cians of various specialties with the purpose of providing
healthcare services to patients and training for specialists.
District hospitals are designated to provide primary
healthcare services, which are similar to those offered by
primary practitioners in clinics providing outpatient serv-
ices.
Quality of care
Quality of care was measured using three groups of indi-
cators: the level of compliance with diagnostic guidelines
during diagnosis, the efficiency of diagnostic and treat-
ment processes, and the outcome of treatment.
The diagnostic process should include a complete exami-
nation of the patient's symptoms, chest X-ray, sputum
smear and cultures. Amongst the diagnostic quality indi-
cators were the percentage of successful collection of at
least three sputum specimens from the patients at the
institution [8-10], and the percentage of patients with a
positive sputum smear who demonstrated negative spu-
tum culture results, which might result from having
received anti-tuberculosis treatment or laboratory errors
[11,12]. For the timeliness of the diagnostic and treatment
process, the number of days, between the chest X-ray
examination and the hospital visit, between the sputum
examination and the hospital visit, laboratory diagnostic
delay and healthcare institution delay were calculated.
The laboratory diagnostic delay was defined as the
number of workdays required for reporting sputum smear
examination results, and the healthcare institution delay
was defined as the number of days from the first related
hospital visit to the initiation of anti-TB medication.
Indicators of the outcome of treatment included the suc-
cessful treatment rate and the fatality rate. The patients
who received successful treatment indicated that they had
been cured or had received complete treatment. A cured
case was defined as a patient with PTB who had com-
pleted treatment with a negative bacteriology result dur-
ing the course of treatment and at the end of treatment. A
case with a completed treatment was defined as a patient
with PTB who had finished treatment, but with no bacte-
riology result at the end of treatment. A fatality case
referred to a patient whose death occurred for any cause
during the course of treatment [13].
Ethical consideration
The CDC approved the present study. All staff involved in
the study signed a letter of agreement to maintain patient
confidentiality.
Data analysis
Chi-square tests were performed to evaluate the differ-
ences in proportions of dichotomous and categorical var-
iables. Since the distributions of indicators of timeliness
were skewed, Kruskal Wallis tests were performed to eval-
uate the differences in these indicators among different
levels of institutions. In addition Mann-Whitney U tests
were used to compare two individual groups of sampled
data. A multiple logistic regression was constructed using
successful treatment or fatality of TB as the dependent var-
iable. Independent variables include age, gender, treat-
ment by the pulmonologist, and treatment at the Chest
Specialty Hospital. Odds ratio (OR) and 95% confidence
interval (CI) of it were used to estimate the effects of inde-
pendent variables on successful treatment and fatality. All
analyses were conducted using SPSS 10.0 statistical soft-
ware, and all statistical tests were performed at the two-
tailed significance level of 0.05.
Results
From January 1 to June 30 2003, 491 patients with TB,
who showed at least two positive sputum smears or a pos-
itive culture, were reported in the study area. Among these
patients, the medical records of 482 (98%) patients were
reviewed. After reviewing medical records, 61 patients
were excluded from the study; including one foreign lab-
orer who was deported after diagnosis, 11 patients with
extrapulmonary tuberculosis, 38 misdiagnosed patients
and 11 patients without any documented positive sputum
smears or positive cultures. Therefore, 421 patients, 311
male (73.9%) and 110 female (26.1%), were included in
the analyses. Patient age at diagnosis ranged from 18 to 95
years, (mean, 66 years), and the number of patients
increased with age (13 below 25 years of age, 35 from 25
to 44 years of age, 110 from 45 to 64 years of age, and 263
above 64 years of age). The majority (95.0%) of patients
were symptomatic, and the most common symptoms
observed were cough (78.8%), fever (41.7%), and dysp-
nea (29.3%). The most common co-morbidity observed
was diabetes (34.3%). No cases of AIDS were observed.
While 134 (31.9%) out of the 420 patients revealed cavi-
tations on chest X-ray examinations, one patient (0.2%)
showed normal findings. Nearly one-half (201; 47.7%) of
patients had provided three or more sputum specimens,
and 392 (93.1%) presented sputum cultures for mycobac-
teria. Fifteen months after treatment was initiated, the rate
of successful treatment among patients who underwent
complete follow-up was 68.9%.
Fifty-four patients (12.8%) were treated at the Chest Spe-
cialty Hospital, 112 (26.6%) at medical centers, 155
(36.8%) at regional hospitals, and 100 (23.8%) at district
hospitals or by primary practitioners (Table 1). The pro-
portion of patients treated by pulmonologists also variedBMC Public Health 2007, 7:107 http://www.biomedcentral.com/1471-2458/7/107
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across different levels of healthcare institutions (p  <
0.001), with the Chest Specialty Hospital containing the
highest proportion of patients.
Most patients (74.1%) provided at least three sputum
specimens for examination at the Chest Specialty Hospi-
tal; however, the proportion was only 48.2%, 36.8%, and
50.0% at medical centers, regional hospitals, and district
hospitals/primary practitioners, respectively (p < 0.001)
(Table 1). A positive sputum smear preceding a negative
sputum culture result was more common at district hospi-
tals/primary practitioners than at other institutions (p <
0.001).
Regarding efficiency in the diagnosis and treatment, the
mean healthcare institution delay was 10.1 days at the
Chest Specialty Hospital, which was shorter than those at
medical centers, regional hospitals, and district hospitals/
primary practitioners (31.0 days, 31.2 days, and 25.4
days, respectively) (p  < 0.01, for all comparisons).
Whereas the number of days between the chest X-ray
examination and the hospital visit were similar, the
number of days between the sputum examination and the
hospital visit varied among different levels of healthcare
institutions (p < 0.05 for both) and was shortest at the
Chest Specialty Hospital. Furthermore, the Chest Spe-
cialty Hospital had the shortest mean laboratory diagnos-
tic delay (2.4 days vs. 2.6 days, 4.5 days, and 3.5 days).
The Chest Specialty Hospital achieved a 92.6% successful
treatment rate, which was higher than medical centers,
regional hospitals, and district hospitals/primary practi-
tioners (65.2%, 63.9%, and 68.0%, respectively, p < 0.01
for all comparisons) (Table 1). Moreover, the fatality rate
at the Chest Specialty Hospital was the lowest among the
institutions (5.6% vs. 27.7%, 32.3%, and 28.0%, p < 0.05
for all comparisons).
Full model and reduced model of multiple regression
analyses revealed that patients of advanced age had less
successful treatment rate, of which OR (95% CI) was 0.97
(0.96, 0.98). The patients who were treated by the pulmo-
nologists and treated at Chest Specialty Hospital had
more successful treatment rate, which OR were 1.74 (1.08,
2.97) and 4.58 (1.58, 13.23) respectively (Table 2). Mean-
while, we also discovered that amongst pulmonologists,
those who provided services at the Chest Specialty Hospi-
tal had more successful treatment rate with OR 4.23 (1.45,
12.40) after adjusting age and gender (Table 3).
Furthermore, the patients of advanced age had more fatal-
ity rate, of which OR 1.06 (1.04, 1.09). The patients who
were treated at Chest Speciatly Hospital had less fatality
with OR 0.20 (0.06, 0.66) (Table 4).






practitioners (n = 100)
Chest specialty 
hospital (n = 54)
P-value
Diagnostic physiciana; n (%) < 0.001
Pulmonologist 76 (67.9) 118 (76.1) 67 (67.0) 53 (98.1)
Non-pulmonologist 36(32.1) 37 (23.9) 33 (33.0) 1 (1.9)
Quality of diagnosis; n (%)
Sputum specimens for diagnosisa < 0.001
<3 specimens 58(51.8) 98 (63.2) 50 (50.0) 14 (25.9)
≥ 3 specimens 54 (48.2) 57 (36.8) 50 (50.0) 40(74.1)
Positive sputum smear but negative sputum culture resultsa < 0.001
Yes 1 (0.9) 12 (7.7) 19 (19.0) 2 (3.7)
No 111 (99.1) 143 (92.3) 81 (81.0) 52 (96.3)
Timeliness (mean ± SD)
Days between chest X-ray examination and the hospital visitb (n = 415) 1.8 ± 6.0 1.8 ± 5.6 1.7 ± 3.4 1.0 ± 0.0 0.044
Days between the sputum examination and the hospital visitb (n = 415) 4.9 ± 13.3 4.1 ± 8.2 4.8 ± 14.7 1.5 ± 2.9 < 0.001
Healthcare institution delay1,b (n = 378) 31.0 ± 53.6 31.2 ± 70.4 25.4 ± 3 7.6 10.1 ± 18.3 < 0.001
Positive AFB smearb (n = 235) 11.2 ± 16.2 13.4 ± 31.4 15.7 ± 30.6 4.7 ± 7.1 0.003
Negative AFB smearb (n = 143) 69.9 ± 76.2 53.3 ± 95.5 44.3 ± 42.8 20.1 ± 27.0 0.001
Laboratory diagnostic delay2,b (n = 415) 2.6 ± 2.1 4.5 ± 3.1 3.5 ± 2.6 2.4 ± 2.4 < 0.001
Outcome; n (%)
Successful treatmenta (n= 421) 0.001
Yes 73 (65.2) 99 (63.9) 68 (68.0) 50 (92.6)
No 39 (34.8) 56(36.1) 32 (32.0) 4 (7.4)
Fatalitya (n = 421) 0.002
Yes 31 (27.7) 50 (32.3) 28 (28.0) 3 (5.6)
No 81 (72.3) 105 (67.7) 72 (72.0) 51 (94.4)
AFB, acid-fast bacilli
aUsing the chi-square test
bUsing the Kruskal Wallis test
1Healthcare institution delay indicates days between the first related hospital visit and the initiation of anti-TB medication
2Laboratory diagnostic delay indicates workdays for reporting sputum smear examination results at the hospitalBMC Public Health 2007, 7:107 http://www.biomedcentral.com/1471-2458/7/107
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Discussion
The persistence of infectious PTB as a major public health
problem results from the presence of individuals with
active infection in whom the disease remains undiag-
nosed or in whom a delay in diagnosis occurs [14-17]. The
varied quality of healthcare provided by public and pri-
vate sectors, and the failure of some healthcare providers
to diagnose tuberculosis promptly and to ensure the deliv-
ery of adequate treatment are two major factors contribut-
ing to the poor control of tuberculosis [18]. Despite the
fact that the NHI program has improved the accessibility
of healthcare services to patients, tuberculosis cases con-
tinue to increase in Taiwan. This phenomenon prompted
our investigation into the variations in care quality for
infectious PTB patients at different levels within health-
care institutions.
In our study, male predominance and elderly susceptibil-
ity to infection by infectious PTB were observed, which are
consistent with other published data [19-21]. Patients
treated at the Chest Specialty Hospital were more likely to
follow the international diagnostic guideline, which is the
presentation of at least three sputum specimens for exam-
ination [9,10]. This might be due to more education and
awareness of infectious PTB among patients cared for at
the Chest Specialty Hospital. A higher proportion of pos-
itive sputum smears with subsequent negative sputum
culture results was observed in district hospitals/primary
practitioners. It is possible that district hospitals/primary
practitioners are not as experienced as larger institutions
or specialty institution. Thus, the laboratory performance
at district hospitals/primary practitioners was not compa-
rable to the quality at larger institutions. Poor laboratory
diagnoses may affect the prescribing of anti-TB medica-
tions by physicians, which in turn may adversely affect the
patient's safety [22]. Sputum smear microscopy is a sim-
ple, inexpensive, and appropriate technique for diagnos-
ing tuberculosis, and laboratories in healthcare
institutions should have qualified technicians performing
this technique [8,9]. Failing this, sputum examinations
should be referred to the central laboratories responsible
for testing sputum specimens in each district [23].
The present study has shown that laboratory diagnostic
delay and healthcare institution delay, regardless of acid-
fast smear, were shorter at the Chest Specialty Hospital,
Table 2: Multiple logistic regression for factors affecting the successful treatment
Fullmodel Reduced model@
Variables Reference group β OR (95% CI) β OR (95% CI)
Age -0.03 0.97 (0.96, 0.98)*** -0.03 0.97 (0.96, 0.98)***
Gender
Female Male 0.18 1.19 (0.72, 1.99)
Physician
Pulmonologist Non-pulmonologist 0.54 1.72 (1.07, 2.77)* 0.55 1.74 (1.08, 2.79)*
Institution
Chest Specialty Hospital Other healthcare institutions 1.54 4.65 (1.61, 13.46)** 1.52 4.58 (1.58, 13.23)**
Hosmer and Lemeshow X2 = 7.25 X2 = 8.57
@ reduced model using forward substitution; * p < 0.05, ** p < 0.01, *** p < 0.001
Table 3: Multiple logistic regression for factors affecting the successful treatment
Full model Reduced modela
Varia bles Reference group β OR (95% CI) β OR (95% CI)
Age -0.04 0.96 (0.94, 0.98)*** -0.04 0.97 (0.94, 0.98)***
Gender
Female Male 0.29 1.33 (0.72, 2.47)
Pulmonologist at
Chest Specialty Hospital Other healthcare institutions 1.44 4.23(1.45, 12.40)** 1.42 4.13 (1.41, 12.05)**
Hosmer and Lemeshow X2 = 9.06 X2=ll.96
areduced model using forward substitution; * p < 0.05, ** p < 0.01, *** p < 0.001BMC Public Health 2007, 7:107 http://www.biomedcentral.com/1471-2458/7/107
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which is most likely due to its greater vigilance for infec-
tious PTB detection. However, even this prompt care can-
not be initiated until a patient has sought or been referred
for treatment. In this regard, patients themselves contrib-
uted to seeking treatment, and such delays were inde-
pendent of the healthcare institution. Further extensive
public health education programs may be necessary to
strengthen the public awareness of infectious PTB and
thereby decrease patient delay in seeking care.
Efficient diagnosis and prompt treatment are the key com-
ponents to the effective control of infectious PTB
[14,24,25]; and, according to practice guidelines for the
treatment of tuberculosis [10], the rate of successful treat-
ment is a good performance indicator of diagnosis and
treatment. The high successful treatment rate observed at
the Chest Specialty Hospital (up to 92.6%), moreover,
after adjusting age and gender, the patients treated at
Chest Specialty Hospital still had more successful treat-
ment rate and less fatality rate. That might be due to the
physicians' expertise with the disease and more efficient
diagnostic and treatment process. Patients treated by pul-
monologists appeared to have a higher successful treat-
ment rate than patients treated by non-pulmonologist
physicians. Perhaps a pivotal factor lies within the unfa-
miliarity non-pulmonologist physicians have with the
treatment of TB patients. Furthermore, the fact that
patients treated by pulmonologists at the Chest Specialty
Hospital had a higher successful treatment rate than those
who were treated by pulmonologists at other institutions
might indicate that both training of care providers and the
institution providing the care are important factors affect-
ing the quality of care. Whereas clinical status and severity
of the disease might affect successful treatment rate and
fatality rates, no variables are available in the database we
obtained to address this issue. Therefore, we were unable
to evaluate the effects of these factors to the results, which
could be a major limitation of the current study. Issues
regarding patient delays have previously been studied [26-
28]. The aim of this study was to identify variations in the
quality of diagnosis and treatment of infectious PTB
patients at different levels within healthcare institutions,
and we found that both training of care providers and the
institution providing the care are important factors affect-
ing the quality of care. Our study showed that non-adher-
ence to a consistent approach to the diagnosis and
treatment for PTB at different levels within healthcare
institutions might result in various successful treatment
rates and that although pulmonologists provided better
care than other physicians, the successful treatment rates
achieved seemed different between pulmonologists at the
Chest Specialty Hospital and pulmonologists at other
institutions. In order to promote the quality of infectious
PTB patient care in Taiwan to the same level as that at the
Chest Specialty Hospital, extensive education programs
and implementation of practice guidelines for tuberculo-
sis for medical staff at the other institutions are strongly
recommended. Furthermore, it is recommended that the
healthcare institutions should also monitor their own
diagnostic quality and the efficiency and effectiveness of
treatment to patients.
Conclusion
Differences in quality of care exist among different types
of healthcare institutions and among individual physi-
cians. The implementation of practice guidelines should
contribute to an improvement in the quality of care in the
treatment and diagnosis of PTB.
List of abbreviations
PTB pulmonary tuberculosis
WHO World Health Organization
CDC Center for Disease Control
AFB acid-fast bacilli
Table 4: Multiple logistic regression for factors affecting the fatality rate
Full model Reduced model@
Variables Reference group β OR (95% CI) β OR (95% CI)
Age 0.06 1.06 (1.04, 1.08)*** 0.06 1.06 (1.04, 1.08)***
Gender
Female Male -0.12 0.89 (0.51, 1.55)
Physician
Pulmonologist Non-pulmonologist -0.36 0.70 (0.42, 1.162)
Institution
Chest Specialty Hospital Other healthcare institutions -1.54 0.21 (0.06, 0.73)* -1.63 0.20 (0.06, 0.66)**
Hosmer and Lemeshow X2 = 7.25 X2 = 4.40
@ reduced model using forward substitution; * p < 0.05, ** p < 0.01, *** p < 0.001Publish with BioMed Central    and   every 
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